Ignyte Bio is excited to announce a major milestone in our journey as we raise $1,000,000 in funding to expand our operations and accelerate innovation in biopharma research. While biopharma research is complex, biosourcing shouldn鈥檛 be, and this investment underscores our commitment to simplifying the process by providing high-quality human immune cells along with custom development and consulting services. Over the years, Ignyte Bio has built a reputation for excellence by leveraging decades of scientific expertise to help leading biopharma companies, contract research organizations, and academic institutions overcome some of the toughest challenges in biomaterial and product development. This new infusion of capital will enable us to enhance our existing capabilities, invest in state-of-the-art laboratory infrastructure, and support the growth of our innovative pipeline. We are poised to expand our research and development teams, thus accelerating our mission to address critical gaps in biosourcing and immune cell provision that hinder scientific progress. Moreover, the funds will be pivotal in scaling our consulting services, allowing us to offer more comprehensive, tailored solutions for complex biopharma demands and further fostering partnerships within the global research community. With this crucial funding, Ignyte Bio is better positioned than ever to offer the scientific rigor and reliable products our clients and partners depend on. We are grateful for the trust placed in us by our investors and remain dedicated to advancing the quality and accessibility of essential biopharma research tools, ultimately contributing to transformative advancements in healthcare and therapeutic development.
Ignyte Bio Secures $1M Seed Investment to Simplify Biosourcing for Biopharma Research
Recently funded 路 $1.0M SeedBiotechnology
Get the full Ignyte Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Apolownia
Apolownia is a mission-driven company committed to making a significant impact in the climate sector. We support businesses and funds willing to engage in long-term and impactful decarbonization strategies - within and beyond their own value chain - by designing, implementing and monitoring science-based carbon reduction projects that restore nature. Through technology and innovative solutions, we aim at shaping a resilient and environmentally friendly world, by encouraging the decarbonization of the economy and supporting social and environmental initiatives. Together, we can drive positive change for the climate, biodiversity and local communities. Contact us to engage or for more information.
$1.2M Seed
1 day ago
Celsio
Celsio is the next-generation electricity provider for sustainable and economical process heat. Using our AI-based algorithm, we trade the flexibility of heat generation systems on volatile electricity markets. This reduces operating costs and avoids emissions.
$1.2M Pre-seed
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Apolownia France | Seed | $1.2M | 1d ago |
| 2 |  Quercus Biosolutions | Seed | $5.0M | 1d ago |
